tiprankstipranks
OKYO Pharma Limited Sponsored ADR (OKYO)
NASDAQ:OKYO
US Market

OKYO Pharma Limited Sponsored ADR (OKYO) Income Statement

Compare
67 Followers

OKYO Pharma Limited Sponsored ADR Income Statement

Last quarter (Q2 2024), OKYO Pharma Limited Sponsored ADR's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, OKYO Pharma Limited Sponsored ADR's net income was $0.00. See OKYO Pharma Limited Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
---$ -13.09K-
Operating Expenses
-$ 13.19M$ 6.22M$ 3.37M$ 1.51M
Depreciation and Amortization
-$ 3.80K$ 2.33K$ 13.11K-
EBITDA
-$ -13.18M$ -6.22M$ -3.35M$ -1.51M
Operating Income
-$ -13.19M$ -6.22M-$ -1.52M
Other Income/Expenses
-$ -96.69K$ 0.00$ 754.85K$ -99.49K
Pretax Income
-$ -13.28M$ -6.22M$ -3.38M$ -1.62M
Net Income
-$ -13.27M$ -5.43M$ -3.35M$ -1.54M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ -0.60$ -0.01$ 0.00$ 0.00
Diluted EPS
$ 0.00$ -0.60$ -0.01$ 0.00$ 0.00
Weighted Average Shares Outstanding
29.34M 22.26M 979.21M 672.77M 595.47M
Weighted Average Shares Outstanding (Diluted)
29.34M 22.26M 979.21M 672.77M 595.47M
Currency in USD

OKYO Pharma Limited Sponsored ADR Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis